How Duodenal Ulcer Medications Work

Duodenal ulcers are open sores that develop on the inner lining of the duodenum, the first part of the small intestine. The primary goal of medication treatment is to reduce acid production and promote healing.

Gold Standard: Proton Pump Inhibitors (PPIs)

Proton Pump Inhibitors (PPIs): PPIs are considered the gold standard for treating duodenal ulcers. They work by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby reducing gastric acid secretion.

• Omeprazole (Prilosec) and lansoprazole (Prevacid) are examples of PPIs commonly used to treat duodenal ulcers.

Alternatives: Histamine-2 Receptor Antagonists (H2RAs), Sucralfate, and Antibiotics for H. pylori Eradication

Histamine-2 Receptor Antagonists (H2RAs): H2RAs work by competitively inhibiting histamine receptors on gastric parietal cells, reducing acid secretion.

• Famotidine (Pepcid) and ranitidine (Zantac) are examples of H2RAs used to treat duodenal ulcers.

Sucralfate: Sucralfate forms an ulcer-adherent complex that protects the ulcer site from acid and enzymes, promoting healing.

• Sucralfate is often used in combination with other medications to enhance healing.

Antibiotics for H. pylori Eradication: In cases where H. pylori infection is present, antibiotics are used to eradicate the bacteria and promote ulcer healing.

• Triple therapy combinations of amoxicillin, clarithromycin, and a PPI are commonly used to treat H. pylori-related duodenal ulcers.